The “Immunoassay Market” highlights the information about the industries and market, technologies, and abilities over the trends and the developments of the industries.
After deep research and analysis by the experts, they also disclosed the data about the strong contenders contributing in the market growth and expansion and challenging one another in terms of demand, supply, production, value estimation, revenue, and sales.
Readers are provided with a detailed outlook of the global Immunoassay Market, which includes carefully calculated revenue and volume growth, CAGR, and market share estimations.
“Immunoassay Market” Research report provide valuable insight with following companies, which includes - Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.p.A.
Immunoassay Market Provides key statistics on the market status of the Market Top players and is a valuable source of guidance and direction for Various companies and individuals are interested in the industry.
On conducting thorough research on the history as well as current growth parameters and growth prospects have been obtained with maximum particularity. Industry report offers an exhaustive analysis of the competitive landscape including thorough company profiling of top players operating in the global Immunoassay Market.
The global immunoassay market has been segmented into product, technology, indication, end user, and region.
By product, the market has been segmented into reagents and kits, analyzers/instruments, software, and services. The reagents and kits segment was the largest value contributor in the global immunoassay market in 2018 due to the rising incidence of chronic and infectious diseases, growing use of reagents and kits along with its repetitive purchase by the users.
On the basis of technology, the market has been divided into radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), enzyme-linked fluorescent assay (ELFA), chemiluminescence immunoassay (CLIA), rapid test, and others.
By indication, the global immunoassay market has been categorized into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious diseases, autoimmune diseases, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
o North America
o South America
o Western Europe
o Eastern Europe
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
The “Medical Imaging Displays Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.
The “Medical Imaging Displays Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such As,
It Provides key statistics on the market status of the Medical Imaging Displays Market players and is a valuable source of guidance and direction for companies and individuals interested in the industry. On conducting thorough research on the history as well as current growth parameters and growth prospects have been obtained with maximum particularity.
The global medical imaging displays market has been segmented by display technology, panel size, resolution, application, and display color.
By display technology, the market has been segmented into LED, TFT-LCD, CRT, PM-LCD, PMOLED, and AMOLED.
By panel size, the market has been segmented into less than 22.9 Inch, 23.0-26.9 Inch, 27.0-41.9 Inch, and more than 42 Inch.
By resolution, the market has been segmented into up to 2MP, 2.1–4MP, 4.1–8MP, and above 8MP.
By application, the market has been segmented into up to diagnostic, general radiology, mammography, digital pathology, multi-modality, surgical/ interventional, dentistry, and others.
The market, by display color, has been segmented into the color display and a monochrome display.
Access complete Premium Research Report along with TOC, List of Figures and Tables at https://www.marketresearchfuture.com/reports/medical-imaging-displays-market-8071
TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
…Continued
Global Medical Imaging Displays Market, by Region:
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Nucleic Acid-based Therapeutics Market these regions, from 2019 to 2023 (forecast), covering North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast
About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Oligonucleotide Synthesis Industry - Overview
Advancing technologies have substantially raised the hope for better treatment in the healthcare sector. One of the chief driving forces is biotechnology which is constantly updating itself and impacting the former sector. Of the many ensuing projects, oligonucleotide synthesis is an evolving technique that forms inexpensive, custom-made oligonucleotides with the desired sequence. Its importance lies in its contribution in DNA or RNA synthesizing and hybridization and in the synthesis of artificial genes.
The global Oligonucleotide Synthesis Industry is expecting an astonishing 10.3% CAGR during the forecast period (2014-2022), reveals Market Research Future (MRFR) in a broadly demonstrated report. The report further incorporates factors that are contributing much for the market growth which includes ventures and investments made by big pharmaceutical companies, contract manufacturing organization’s involvement in the market and global prevalence of chronic diseases spurring the demand for better medicines.
However, the cost can prove to be a great market deterrent. The oligonucleotide synthesis requires expert hands, and its research and development process can incur high expenditure which can impede the growth in the near future. But it has the potential to counter chronic diseases by developing suitable drugs which can create a favorable ambiance for the market.
Oligonucleotide Synthesis Industry Segmentation:
The global Oligonucleotide Synthesis Industry can be segmented by product type, application, and end-users.
Based on product type, the market can be segmented into synthesized oligonucleotides, reagents and equipment.
Application-wise segmentation of the market includes diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others.
Based on end-users, the market comprises academic research institutes, diagnostic laboratories, and pharmaceutical & biotechnology companies.
Healthcare Mobility Solutions Industry Introduction
There has been a huge transformation in the health sector as they have been one of the first adopters of advanced mobile technology within their products and services. By quickly recognizing the benefits yielded by the mobile enabled applications, health care providers have overcome most of the challenges faced by them.
Healthcare mobility solutions are the new age technological advancements in the field of healthcare. Healthcare mobility solutions enables the medical professional to provide the best possible medical service in less time with the use of various mobile applications and services. Mobility solutions also help in reducing the overall healthcare cost.
Healthcare Mobility Solutions Industry Key Players
Airstrip Technologies, Inc. (U.S.), At&T, Inc. (U.S.), Cerner Corporation (U.S.), Cisco Systems, Inc. (U.S.), Codecube (India), FuGenX Technologies (U.S.), FUTURA MOBILITY LLC(U.S.), Infosys limited (U.S.), Mckesson Corporation (U.S.), Omron Corporation (Japan), Oracle Corporation (U.S.), Philips Healthcare (U.S.), SAP SE (Germany), Wipro Limited (India), Zebra Technologies Corporation (U.S.), [x]cube LABS (U.S.), are some of the prominent players at the forefront of competition in the Global Healthcare Mobility Solutions Industry and are profiled in MRFR Analysis.
Healthcare Mobility Solutions Industry Segmentation
The market for healthcare mobility solutions is characterised by the presence of several well-established and small players, the global market of healthcare mobility solutions appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The Healthcare Mobility Solutions Industry appears to be highly competitive owing to the presence of several large and small key players accounting for a substantial market share. Well established players incorporate partnership, expansion, and technology launch in order to gain competitive advantage in this market and to maintain their market position.
In February 2016, Extension Healthcare signs an exclusive distribution agreement with Airstrip delivers patient waveform data in near-real-time with sharp, full detail and the highest possible resolution on mobile devices. This will help the company to extend their distribution all around the United States.
Moreover, in February 2015, - AirStrip and Life Monitor Pty Ltd., a subsidiary of Cardioscan Pty Ltd., signed a strategic partnership to sell AirStrip solutions in Australia and New Zealand. Both the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system will be sold by the company as part of the agreement. By serving as a catalyst for customer innovation, the company will quickly become the leading providers in Australia and New Zealand.
Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/1970
Healthcare Mobility Solutions Industry is growing rapidly post 2016 with the CAGR of ~24%, thus growth period of this market can be stated as from 2017-2022. According to a recent study report published by the Market Research Future, the global Healthcare Mobility Solutions Industry is booming and expected to gain eminence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a prominent CAGR during the anticipated period (2017 – 2022).
AstraZeneca (U.K), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), GE Healthcare (U.K), AbbVie Inc. (U.S.), Hologic (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Bayer AG (Germany) are some of the leading players at the cutting edge of the competition in the market of Uterine Fibroid.
Uterine fibroids Industry are the noncancerous growths of the uterus, which mostly appear during childbearing years. It is the abnormal growth of that gets developed inside or on the wall of a woman’s uterus. Uterine fibroids is also known as myomas or leiomyomas. The symptom of uterine fibroids are frequent urination, constipation, backache, heavy menstrual bleeding, pelvic pressure, or menstrual periods lasting more than a week. The women with mild symptoms may go for medical treatments such as hormonal drugs, gonadotropin agonists, progestin and oral contraceptives. Women with moderate to severe symptoms may need surgery to treat uterine fibroids. According to the U.S. Department of Health and Human Services office on Women Health, about 20% to 80% of women develop fibroids by the age of 50 and nearly 30% will get them at the age of 35. Uterine fibroids are most common in women in their 40s and early 50s.
United States Uterine Fibroid Industry – Overview
The United States Uterine Fibroid Industry is showing the significant growth; mainly due to change in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries. Additionally rising in aging population also leads the Uterine Fibroid Industry with in this region. According to U.S. Department of Health and Human Services, study found that before 50s 70% of white and 80% of African Americans are diagnosed with fibroids. Also more than 200,000 hysterectomies are performed each year for uterine fibroids. Hysterectomies is the surgery that is used to remove the uterus, if the condition is painful.
United States Uterine Fibroid Industry - Regional Analysis
The market of Uterine Fibroid devices is much higher in the United States region, owing to its high prevalence in African- American race, change in lifestyle. According to one large cohort study of NIS on African-American women in Maryland, uterine fibroids was the cause of 65.4% of total 53,000 women undergoing hysterectomy.
Moreover, most of the major market players belong from this region, thus they introduce the advance technology firstly in the United States in comparison to others region.
Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/2394
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Ultrasound Devices Industry Driven by Growing Demand for Noninvasive Medical Imaging and Diagnosis
Ultrasound devices work by sending out high-frequency sound waves that provide a picture of the targeted area based on the response of various bodily tissues to the sound waves.
The global Ultrasound Devices Industry is expected to exhibit a strong 8.1% CAGR over the forecast period,
Ultrasound Devices Industry Segmentation:
The Global Ultrasound Devices Market is segmented by application into diagnostic and therapeutic. The diagnostic application segment holds a dominant share of 68% in the global Ultrasound Devices Industry and is likely to remain the leading contributor over the forecast period.
On the basis of branch of medicine, the Ultrasound Devices Industry is segmented into radiology, OB/GYN, cardiac, and others.
By product type, the global Ultrasound Devices Industry is segmented into cart-based and portable.
By end user, the global Ultrasound Devices Industry is segmented into hospitals/clinics and ambulatory care centers.
Ultrasound Devices Industry Competitive Analysis:
Leading players in the global Ultrasound Devices Industry include Siemens AG, GE, Hitachi Ltd., Shimadzu Corporation, Analogic Corporation, Mindray Medical International Ltd., Toshiba Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips NV.
In March 2019, security specialist Check Point Software Technologies said in a report that ultrasound devices running on older operating systems such as Windows 2000 were virtually defenseless against modern hackers, which could result in the hackers gaining access to confidential hospital information and making exorbitant ransom demands on the hospital. Eliminating this threat is likely to be top of the agenda for the leading players in the global Ultrasound Devices Industry over the forecast period.
Brows Complete Premium Research Report@ https://www.marketresearchfuture.com/reports/ultrasound-devices-market-2789
The growing demand for more advanced ultrasound devices in the gynecology sector is likely to be a major driver for the global Ultrasound Devices Industry over the forecast period. The development of 3D and 4D ultrasound imaging has allowed for the diagnosis of congenital defects clearly and earlier in the pregnancy, which has made the procedures widely popular in the healthcare sector around the world. 4D imaging also allows live action viewing of the fetus, which allows physicians to detect more abnormalities. This is likely to be a major driver for the global Ultrasound Devices Industry over the forecast period.
Surgical Robots Industry Regional Outlook:
America region is currently dominates the market of surgical robots in the healthcare industry.
European Market currently holds the second largest market share of surgical robots industry.
On the other hand, Asia Pacific region is relatively slow in implementing the use of surgical robots in the healthcare sector.
Surgical Robots Industry Outlook
According to a recent study report published by the Market Research Future analysts, the global Surgical Robots Industry is growing at a moderate pace; Robotic surgery has advantages over traditional open surgeries such as greater precision, miniaturization, less pain, smaller incisions and scars, low blood loss, and quicker healing time. Another benefit is greater articulation due to better manipulation resulting in improved ergonomics. Due to the combined effects of the above mentioned benefits there is a reduced duration of hospital stays.
Surgical Robots Industry Competitive Dashboard:
Intuitive Surgical Inc., Medtronic plc, Johnson & Johnson, Google Life Sciences, Stryker Corporation, TransEnterix, Mazor Robotics, and Hansen Medical are some of the prominent players at the forefront of competition in the Global Surgical Robots Industry and are profiled in MRFR Analysis.
Segmentation:
Global Surgical Robots Industry is segmented on the basis of control mechanism into direct telemanipulator and computer control.
On the basis of robotic surgery approach they are supervisor-controlled robotic surgical system, shared control robotic surgical systems, telesurgery systems, robotic radiosurgery systems and on the basis of application they are segmented into general surgery, cardiac surgery, gynecologic surgery, colorectal surgery, urologic surgery, head and neck surgery and other
However the system is not without critics which includes the American Congress of Obstetricians and Gynaecologists. The system is criticized for its steep learning curve and for its lack of studies indicating superiority over traditional surgeries. Another serious disadvantage has been the high cost of the surgical robots. Surgical robots may cost close to 1.5 million USD with the cost of disposable supply exceeding 1000 USD per procedure. All these factors may hinder the growth of this market in the near future.
Smart Insulin Pens Industry are medical devices used to inject the insulin in patients’ body. Smart insulin pens are less painful and more effective than other drug delivery devices.
Global Smart Insulin Pens Industry Accounted for USD 60 Million And Is Expected to Register A 10.4% CAGR During The Forecast Period (2018–2023)
Key Players:
Some of the key players in the global Smart Insulin Pens Industry are Sanofi-Aventis US LLC., Lilly Novo Nordisk A/S, USA, LLC, Digital Medics Pty Ltd., Companion Medical, Emperra GmbH E-Health Technologies, Biocorp, Diamesco Co., Ltd., Smiths Medical, NIPRO Medical Corporation, and InjexUK
Get Sample Research Report at https://www.marketresearchfuture.com/sample_request/6789
Segmentation:
The global Smart Insulin Pens Industry has been segmented on the basis of product type, usability, and distribution channel.
The product type segment has been classified as first-generation pens and second-generation pens. The second-generation pens segment has been further divided into Bluetooth-enabled and USB connected.
The market, by usability, has been segmented into disposable pens and reusable pens. Reusable insulin pens segment is likely to be the fastest growing segment during the forecast period.
On the basis of the distribution channel, the market has been divided into online medical stores, retail pharmacies, diabetes clinics, and hospital pharmacies.
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789
Regional Analysis:
The Americas are likely to dominate the global Smart Insulin Pens Industry due to the increasing prevalence of diabetes, favorable policies government and regulatory policies, and high adoption rate of advanced technology. The European market is expected to be the second-largest Smart Insulin Pens Industry. The growing acceptance of advanced drug delivery devices, the presence of major market players in the region, and rising diabetic population in the region are the factors responsible for the growth of the Smart Insulin Pens Industry in the region. Asia-Pacific is anticipated to be the fastest-growing Smart Insulin Pens Industry during the forecast period owing to the increase in population, rising prevalence of diabetes, and government initiatives for the development of the healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global Smart Insulin Pens Industry.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Global Smart Pills Industry by Application (Patient Monitoring and Others), Target Area (Esophagus, Small Intestine, and Others), Disease Indication (Disease Indication, and Others) End User (Hospitals and Others)—Global Forecast till 2023
According to the National Diabetes Statistics Report published by Centers for Disease Control and Prevention, in 2015, In the US 1.5 million new cases of diabetes were registered and approximately USD 245 billion spent on diagnosis and treatment of diabetes
The global Smart Pills Industry accounts for USD 1,800 million and expected to register healthy CAGR ~14.2% during the forecast period.
Get Exclusive Copy of Report at https://www.marketresearchfuture.com/sample_request/6591
Market Driving Key Players
Some of the key players in the global Smart Pills Industry are Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., MEDTRONIC, FUJIFILM Holdings Corporation, RF Co., Ltd., Check-Cap, BDD Limited, JINSHAN Science & Technology, MEDISAFE, PENTAX Medical, and INTROMEDIC.
Global Smart Pills Industry Has Been Segmented On The Basis Of Application, Target Area, Disease Indication, And End-User.
On the basis of application, the market has been classified capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further divided into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. Patient monitoring segment has been divided into capsule pH monitoring and others.
Smart pills on the basis of the target area have been segmented into esophagus, small intestine, large intestine, and stomach.
The disease indication segment is divided into esophageal diseases, small bowel diseases, colon diseases, and others.
The market, by end-user, has been segmented into hospitals, diagnostic center, and research institute.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Smart Pills Industry in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Smart Pills Industry has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Smart Pills Industry in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Smart Pills Industry in the Middle East & Africa has been segmented into the Middle East and Africa.
Brows Complete Detailed Report at https://www.marketresearchfuture.com/reports/smart-pills-market-6591
The Americas are expected to dominate the global Smart Pills Industry owing to the favorable reimbursement policies, increasing prevalence of chronic diseases, and adoption of highly advanced technology.
The European market is expected to be the second-largest Smart Pills Industry.
Asia-Pacific is expected to be the fastest-growing Smart Pills Industry during the forecast period owing to the increasing geriatric population in the region, continuously increasing investment in healthcare and the adoption of technology in healthcare.
The market in the Middle East & Africa is expected to account for the smallest share of the global Smart Pills Industry due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Orthopaedic Implants Industry Overview:
Orthopaedic Implants Industry is experiencing a surge in sale across the globe, and it has been considerably boosted by technological advancement. The global Orthopaedic Implants Industry can expect a 6.8% CAGR during the forecast period (2017-2023), reveals Market Research Future (MRFR) in a detailed study.
The global Orthopaedic Implants Industry can be segmented by product type, procedure, biomaterial, device type, application, and end-user.
Based on product type, the Orthopaedic Implants Industry can be segmented into spinal implants, dental implants, trauma and craniomaxillofacial implants, reconstructive joint implants, orthobiologics, and others.
Procedure-wise, the Orthopaedic Implants Industry includes open surgery, minimally invasive surgery (MIS), and others.
Biomaterial-based segmentation of the Orthopaedic Implants Industry includes metallic biomaterials, polymer biomaterials, ceramic biomaterials, and natural biomaterials.
Based on the device type, the Orthopaedic Implants Industry includes internal fixation devices and external fixation devices. External fixation devices are further subdivided into Orthopaedic rods/wires, Orthopaedic screws, Orthopaedic plates, fixation pins, and Orthopaedic nails.
Application-wise, the Orthopaedic Implants Industry comprises neck fracture, spine fracture, hip replacement, shoulder replacement, and others.
Based on end-user, the Orthopaedic Implants Industry consists hospitals, Orthopaedic clinics, home cares, and others.
Some major players in the global Orthopaedic Implants Industry include Depuy Synthes Inc. (Johnson & Johnson) (U.S.), Globus Medical, Inc. (U.S.), NuVasive, Inc. (U.S.), Smith & Nephew plc. (UK), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Medtronic, plc (Ireland), The Orthopaedic Implant Company (U.S.), Wright Medical Group N.V. (Netherlands), Aesculap Implant Systems (U.S.), BioTek Instruments, Inc. (U.S.), Conmed Corporation (U.S.), Arthrocare Corporation (U.S.), and others.
The study includes Orthopaedic Implants Industry drivers such as increasing prevalence of Orthopaedic conditions such as fractures, osteoporosis, arthritis and technological advancement which has led to the use of more sophisticated implants. Obesity, sedentary lifestyle and adventure sports are instigating such diseases. Furthermore, governments are also investing much in research and developments that are helping the market gain momentum. At the same time, developing countries are opening up wide spaces for Orthopaedic Implants Industry to expand.
Contact:
+1 646 845 9312 | Email: salesmarketresearchfuture.com
Embolic Protection Devices Industry Highlights
Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures. Other key factors such as advancement in the field of healthcare and adoption of advanced equipment by healthcare institutes also drive the growth of the market. However, factors such as lack of trained medical professionals are expected to curb the growth of the market during the forecast period.
Global Embolic Protection Devices Industry: Embolic Protection Devices: Increasing prevalence of rate in cardiovascular disorders is likely to drive the growth of the global market at a CAGR of 8.5% during 2018 to 2023.
Industry Segmentation
The global Embolic Protection Devices Industry is segmented on the basis of type, material, usage, application, and end-user.
On the basis of type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices.
On the basis of material, the market is segmented into nitinol and polyurethane.
On the basis of usage, the market is segmented into disposable devices and reusable devices.
On the basis of application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. On the basis of cardiovascular diseases, it is further sub-segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft diseases.
On the basis of the end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers.
Competitive Analysis by Major Key Players
Medtronic
Abbott Laboratories
Boston Scientific
Cordis
Contego Medical
Silk Road Medical
Claret Medical
Allium Medical Solutions
Angioslide
Claret Medical
Edwards Lifesciences Corporation
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/embolic-protection-devices-market-5978
Comprehensive Regional Analysis
The Americas dominates the global Embolic Protection Devices Industry owing to the increasing aging population, which eventually leads to the increasing patient population. According to the American Heart Association, 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S.
Europe accounts for the second largest market due to the increasing cardiovascular disorders and increasing obesity rates. For instance, Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above. This rising older population is likely to lead to the increased patient population. These factors are likely to drive the growth of the Embolic Protection Devices Industry.
Asia Pacific is the fastest growing market for the embolic protection devices whose growth is attributed to rising population and increasing standard of living.
On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312